Coronavirus/COVID-19, Pharmaceutical Industry, Cybersecurity

False Claims Act Settlements to Know from the First Half of 2025

Bass, Berry & Sims PLC on 8/12/2025

With the first half of 2025 in the rearview mirror, the government’s continued focus on False Claims Act (FCA) enforcement shows no signs of slowing. In fact, the Department of Justice recently announced the results of a...more

[Event] 11th Annual Advanced Forum on False Claims and Qui Tam Enforcement - January 23rd - 24th, New York, NY

American Conference Institute (ACI) on 11/22/2023

Hosted by American Conference Institute, the 11th Annual Advanced Forum on False Claims and Qui Tam Enforcement returns for another exciting year for lively discussions on FCA enforcement including the ramifications of two...more

[Event] 2023 Healthcare Enforcement Compliance Conference - November 5th - 7th, Washington, DC

Health Care Compliance Association (HCCA) on 8/8/2023

Hear directly from the enforcement community - Want to gain insight into properly monitoring, detecting, investigating, and managing violations? Join us at HCCA’s Annual Healthcare Enforcement Compliance Conference to...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 98

Jones Day on 3/22/2023

This regular update (no. 98 | 1 March 2023) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective...more

DOJ Releases False Claims Act Statistics for Fiscal Year 2022

Morrison & Foerster LLP on 2/15/2023

On February 7, 2023, the U.S. Department of Justice (DOJ) announced its fiscal year (FY) 2022 False Claims Act (FCA) statistics. Utilizing DOJ’s FY 2022 Data Table and comparing back to our FY 2021 coverage, MoFo’s FCA team...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 95

Jones Day on 1/31/2023

This regular update (no. 95 | 9 January 2023) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 91

Jones Day on 11/22/2022

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion....more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 86

Jones Day on 9/26/2022

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. ...more

Clinical ColLABorative - Legal Insights in Laboratory Compliance

Robinson & Cole LLP on 7/15/2022

What To Do When The Government Knocks On Your Lab’s Door - The volume of federal enforcement actions involving laboratories has increased dramatically over the last few years. Not a month seems to pass without a press...more

Covid-19 Key EU Developments, Policy & Regulatory Update No. 85

Jones Day on 7/5/2022

COMPETITION & STATE AID - State Aid - European Commission approves new and amended Member State measures to support the economy - Since the onset of the coronavirus outbreak, the Commission has adopted a significant number...more

And So It Begins: House Energy and Commerce Leaders Unveil FDA User Fees Legislative Package

King & Spalding on 5/11/2022

On May 4, 2022, House Energy and Commerce (“E&C”) Committee leaders unveiled the legislative package to reauthorize the U.S. Food and Drug Administration (“FDA” or the “Agency”) user fee agreements (the “House Draft”)...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 80

Jones Day on 4/28/2022

COMPETITION & STATE AID - State Aid - European Commission adopts Temporary Crisis Framework to support economy in context of Russia's invasion of Ukraine - On 23 March 2022, the Commission adopted a Communication on a...more

Covid-19 Key EU Developments, Policy & Regulatory Update No. 78

Jones Day on 3/24/2022

COMPETITION & STATE AID - State Aid - European Commission publishes first Report on implementation of Recovery and Resilience Facility - On 1 March 2022, the Commission published its first Report to the European...more

Health Care Enforcement Year In Review & 2022 Outlook

Mintz - Health Care Viewpoints on 2/11/2022

STATISTICAL TRENDS IN FALSE CLAIMS ACT LITIGATION - FCA case activity for 2021 reveals seemingly contrary trends. For the federal fiscal year (FY) that ended September 30, 2021, the DOJ annual report on FCA enforcement...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 73

Jones Day on 2/4/2022

COMPETITION & STATE AID - Competition - Commission publishes Competition Policy – 2021 at a glance. On 22 December 2021, the European Commission published its Competition Policy – 2021 at a glance. ...more

Weekly Update for Government Contractors and Commercial Businesses – February 2022

PilieroMazza PLLC on 2/4/2022

DOJ Recovers Over $5.6 Billion From Fraud and False Claims Act Matters in FY 2021: 6 Key Takeaways - On February 1, 2022, the U.S. Department of Justice (DOJ) announced that it had recovered more than $5.6 billion in Fiscal...more

FDA Extends Pause on Non-mission-critical Domestic Surveillance inspections to February 4 – Medical Products Supply Chain Week in...

Alston & Bird on 2/1/2022

In this week’s issue, OSHA withdrew its emergency temporary standard (ETS), which required a mandatory vaccination policy for large private employers with an exception for employers that adopt a policy requiring mandatory...more

Coronavirus/COVID-19 › Pharmaceutical Industry › Cybersecurity

False Claims Act Settlements to Know from the First Half of 2025

[Event] 11th Annual Advanced Forum on False Claims and Qui Tam Enforcement - January 23rd - 24th, New York, NY

[Event] 2023 Healthcare Enforcement Compliance Conference - November 5th - 7th, Washington, DC

COVID-19 Key EU Developments, Policy & Regulatory Update No. 98

DOJ Releases False Claims Act Statistics for Fiscal Year 2022

COVID-19 Key EU Developments, Policy & Regulatory Update No. 95

COVID-19 Key EU Developments, Policy & Regulatory Update No. 91

COVID-19 Key EU Developments, Policy & Regulatory Update No. 86

Clinical ColLABorative - Legal Insights in Laboratory Compliance

Covid-19 Key EU Developments, Policy & Regulatory Update No. 85

And So It Begins: House Energy and Commerce Leaders Unveil FDA User Fees Legislative Package

COVID-19 Key EU Developments, Policy & Regulatory Update No. 80

Covid-19 Key EU Developments, Policy & Regulatory Update No. 78

Health Care Enforcement Year In Review & 2022 Outlook

COVID-19 Key EU Developments, Policy & Regulatory Update No. 73

Weekly Update for Government Contractors and Commercial Businesses – February 2022

FDA Extends Pause on Non-mission-critical Domestic Surveillance inspections to February 4 – Medical Products Supply Chain Week in...

COVID-19 Key EU Developments, Policy & Regulatory Update No.72

COVID-19 Key EU Developments, Policy & Regulatory Update No. 71

COVID-19 KEY EU Developments, Policy & Regulatory Update No. 70

COVID-19 Key EU Developments, Policy & Regulatory Update No.69

COVID-19 Key EU Developments, Policy & Regulatory Update No. 68

COVID-19 Key EU Developments, Policy & Regulatory update No.67

Congressional Investigations in the 117th Congress: U.S. Senate Oversight Activities Ramp Up

[Virtual Event] 2021 Regional Healthcare Compliance Conference - New Orleans - April 9th, 8:25 am - 4:30 pm CDT

Coronavirus/COVID-19 › Pharmaceutical Industry › Cybersecurity

"My best business intelligence, in one easy email…"